Literature DB >> 7684074

Pathology and biology of the Lewy body.

M S Pollanen1, D W Dickson, C Bergeron.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 7684074     DOI： 10.1097/00005072-199305000-00001

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN： 0022-3069            Impact factor:   3.685


× No keyword cloud information.
  79 in total

1.  Neuropathology in mice expressing human alpha-synuclein.

Authors:  H van der Putten; K H Wiederhold; A Probst; S Barbieri; C Mistl; S Danner; S Kauffmann; K Hofele; W P Spooren; M A Ruegg; S Lin; P Caroni; B Sommer; M Tolnay; G Bilbe
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

2.  Cell type specific sequestration of choline acetyltransferase and tyrosine hydroxylase within Lewy bodies.

Authors:  Brittany N Dugger; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2010-08-19       Impact factor: 17.088

3.  Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein.

Authors:  J E Galvin; K Uryu; V M Lee; J Q Trojanowski
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

4.  Atypical dopa responsive parkinsonism in a patient with megalencephaly, midbrain Lewy body disease, and some pathological features of Hallervorden-Spatz disease.

Authors:  P J Tuite; J P Provias; A E Lang
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-11       Impact factor: 10.154

5.  A close association of torsinA and alpha-synuclein in Lewy bodies: a fluorescence resonance energy transfer study.

Authors:  N Sharma; J Hewett; L J Ozelius; V Ramesh; P J McLean; X O Breakefield; B T Hyman
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

6.  Amygdala pathology in Parkinson's disease.

Authors:  H Braak; E Braak; D Yilmazer; R A de Vos; E N Jansen; J Bohl; K Jellinger
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

7.  alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.

Authors:  C Lo Bianco; J-L Ridet; B L Schneider; N Deglon; P Aebischer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-16       Impact factor: 11.205

8.  Protective effects of resveratrol on glutamate-induced damages in murine brain cultures.

Authors:  Rudolf Moldzio; Khaled Radad; Christopher Krewenka; Barbara Kranner; Johanna Catharina Duvigneau; Wolf-Dieter Rausch
Journal:  J Neural Transm (Vienna)       Date:  2013-03-05       Impact factor: 3.575

9.  Tissue transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies.

Authors:  Eunsung Junn; Ruben D Ronchetti; Martha M Quezado; Soo-Youl Kim; M Maral Mouradian
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-07       Impact factor: 11.205

Review 10.  Parkinson's disease and parkinsonism: neuropathology.

Authors:  Dennis W Dickson
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.